Johnson & Johnson (JNJ) Issues Q1 'Beat-and-Raise' Led By Pharma Business
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $270.98 +3.28%
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) shares are up following better-than-expected first-quarter results and the company's raised guidance that is set ahead of the Street.
The company reported first-quarter earnings of $1.35 per share, nine cents better than the analyst estimate of $1.26 per share.
Revenue for JNJ rose 3.5 percent to $16.2 billion in the three-month period ended March 31, topping the market consensus of $15.83 billion.
Domestic sales fell 0.6 percent in the period, while revenue from international markets rose 7.3 percent.
"Our pharmaceuticals business demonstrated strong growth this quarter led by the performance of recently launched products. We delivered solid earnings while making the investments necessary to advance the robust pipelines across our businesses," said William C. Weldon, Chairman and Chief Executive Officer.
Looking forward, the company raised its full year 2011 earnings guidance to $4.90 - $5.00 per share, ahead of the estimate of $4.83 per share. The company had previously guided for full year earnings of $4.80 - $4.90 per share.
Shares of JNJ are up 2.13 percent to $61.75 in premarket trade on Tuesday.
The company reported first-quarter earnings of $1.35 per share, nine cents better than the analyst estimate of $1.26 per share.
Revenue for JNJ rose 3.5 percent to $16.2 billion in the three-month period ended March 31, topping the market consensus of $15.83 billion.
Domestic sales fell 0.6 percent in the period, while revenue from international markets rose 7.3 percent.
"Our pharmaceuticals business demonstrated strong growth this quarter led by the performance of recently launched products. We delivered solid earnings while making the investments necessary to advance the robust pipelines across our businesses," said William C. Weldon, Chairman and Chief Executive Officer.
Looking forward, the company raised its full year 2011 earnings guidance to $4.90 - $5.00 per share, ahead of the estimate of $4.83 per share. The company had previously guided for full year earnings of $4.80 - $4.90 per share.
Shares of JNJ are up 2.13 percent to $61.75 in premarket trade on Tuesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Airgain wins two IoT modem deals for AI data center power systems
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
